Prognostic significance of albumin-bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapy.
Dezuo DongXianggao ZhuHongzhi WangLijuan LiMeng WanShuai LiYangzi ZhangJianhao GengYongheng LiWei-Hu WangPublished in: Journal of medical imaging and radiation oncology (2022)
Combined ICI and RT is an effective modality for treating unresectable HCC with moderate side effects. ALBI scores merits consideration when applying this combined treatment modality. These results should be validated within large cohort studies.